MusclePharm Corporation MSLP OTC

Other OTC • Consumer Defensive • Packaged Foods • US • USD

SharesGrow Score

11/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MusclePharm Corporation (MSLP) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 11/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

11/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

7/100

→ Income

✗

成长

15/100

→ Income

✗

收入

10/100

→ Income

估值概览 — MSLP

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.31

每股账面价值$0.00

每股营收$1.22

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2012	$-18.02	$67.06M	$-26.29M	-39.2%
2013	$-2.46	$110.88M	$-17.72M	-16%
2014	$-1.25	$177.39M	$-13.83M	-7.8%
2015	$-3.81	$166.86M	$-51.86M	-31.1%
2016	$-0.26	$132.5M	$-3.48M	-2.6%
2017	$-0.79	$102.16M	$-10.97M	-10.7%
2018	$-0.72	$88.11M	$-10.76M	-12.2%
2019	$-0.92	$79.67M	$-18.93M	-23.8%
2020	$0.08	$64.44M	$3.19M	4.9%
2021	$-0.31	$50.04M	$-12.88M	-25.7%